Patients with psoriasis have an increased risk of suicidal ideation and behavior (SIB) and depression. Bimekizumab, an interleukin (IL)-17A and IL-17F inhibitor, was approved for the treatment of...
CURATED BY: Renee Ott, MSN, CNP
Renee Ott,
MSN, CNP
Family Nurse Practitioner, Dermatologists of Central States
Managing Psoriasis in Older Patients: Balancing Treatment Efficacy and Increased Risks
Psoriasis treatments for patients of all ages often include topicals, phototherapy, oral agents like methotrexate and cyclosporine, new oral inhibitors,...
Renee Ott,
MSN, CNP
Family Nurse Practitioner, Dermatologists of Central States
LITE Study Shows Home-Based Phototherapy Effective for Psoriasis, Boosts Treatment Adherence
Researchers of the LITE Study demonstrated that home-based phototherapy for psoriasis is non-inferior to office-based phototherapy across all skin types...
Renee Ott,
MSN, CNP
Family Nurse Practitioner, Dermatologists of Central States
Addressing Treatment Challenges in Multi-Resistant Patients With Psoriasis: Promising Results With IL-23 Inhibitor
This letter to the editor addresses the treatment challenges for psoriasis patients resistant to multiple biological therapies, proposing categorizing those...
Lisa Weiss,
MMSc, PA-C
Medical and Cosmetic Dermatology Physician Associate, Dermatology and Skin Surgery Center
